Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.
about
Pathogenesis of diabetic cerebral vascular disease complicationPGC-1alpha inhibits oleic acid induced proliferation and migration of rat vascular smooth muscle cells.Association of genetic factors with selected measures of physical performance.Nonesterified fatty acids in blood pressure control and cardiovascular complications.Diabetes-related microvascular and macrovascular diseases in the physical therapy settingQuantitative trait loci on chromosomes 3 and 17 influence phenotypes of the metabolic syndrome.Inflammation and its association with glucose disorders and cardiovascular disease.Association of Angiotensin Converting Enzyme Insertion-Deletion Polymorphism with Hypertension in Emiratis with Type 2 Diabetes Mellitus and Its Interaction with Obesity Status.Diabetes mellitus and stroke.Adipose tissue metabolism, diabetes and vascular disease--lessons from in vivo studies.Blood pressure control in patients with comorbidities.Low-dose statin therapy improves endothelial function in type 2 diabetic patients with normal serum total cholesterol: a randomized placebo-controlled study.Association of angiotensin-converting enzyme insertion/deletion polymorphism with obesity, cardiovascular risk factors and exercise-mediated changes in Korean women.Systemic resistance to the antilipolytic effect of insulin in black and white women with visceral obesity.Relationships of plasma leptin levels to changes in plasma free fatty acids in women who are lean and women who are abdominally obese.The renin-angiotensin system in obesity hypertension.Human angiotensin I-converting enzyme gene and endurance performance
P2860
Q28087462-24F14FB3-CB16-4770-84DF-85B52FFCBC0CQ33305208-E7059CBD-2835-4F12-B74C-E7A03B63C258Q33875361-4AEBB557-39DF-4DD2-8777-6C26ABA12E93Q34199957-1580289C-C404-45D0-8252-A0564ADB61C7Q34830905-101F36E0-3ACC-4A40-8A03-1D7255AAEA2AQ35846048-6712E2BD-8FAA-464D-8107-FD9005B5AC9FQ36116347-D0450EA9-7515-4131-B42F-D06B5EA55928Q36155745-B689C4FC-00D4-42DD-A0AF-F08FE21C069DQ36366998-F687A548-DE5A-4ED5-BA58-C5207DD911D9Q36511220-4817690E-00A0-496F-996C-7E74B8FD2AC5Q37261257-2290FBFB-8860-48F5-8F06-3CF9FF063AB7Q42844807-749B95E5-AB10-48A0-B00C-94D42DF14CD5Q46174167-78BD3CAD-90CF-4220-93A3-0015F83C2341Q46707374-8866FEFE-193A-4157-842B-6F93C3BCE2AEQ51572583-277DD759-65CD-4128-BC04-F9E85B39DDA8Q52966124-95593CFE-26BE-4629-AAA9-CF7D221126FAQ57113794-2BE96F8A-51A0-4C2C-BF40-667BE4381969
P2860
Insulin-resistant lipolysis in abdominally obese hypertensive individuals. Role of the renin-angiotensin system.
description
1996 nî lūn-bûn
@nan
1996年の論文
@ja
1996年論文
@yue
1996年論文
@zh-hant
1996年論文
@zh-hk
1996年論文
@zh-mo
1996年論文
@zh-tw
1996年论文
@wuu
1996年论文
@zh
1996年论文
@zh-cn
name
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@en
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@nl
type
label
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@en
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@nl
prefLabel
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@en
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@nl
P2093
P356
P1433
P1476
Insulin-resistant lipolysis in ...... the renin-angiotensin system.
@en
P2093
A H Kissebah
I M O'Shaughnessy
M M Hennes
P304
P356
10.1161/01.HYP.28.1.120
P407
P577
1996-07-01T00:00:00Z